Literature DB >> 9920112

Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.

S Nimkarn1, B I Cerame, J Q Wei, M Dumic, R Zunec, L Brkljacic, V Skrabić, M I New, R C Wilson.   

Abstract

Congenital adrenal hyperplasia (CAH) owing to 21-hydroxylase deficiency (21-OHD) is the most common inherited defect of adrenal steroid biosynthesis. At least 36 mutations in the CYP21 gene, which is mapped to chromosome 6p21.3, have been described. We performed genetic analysis of the CYP21 gene in a patient with classic 21-OHD CAH and her family. The entire exonic coding regions and intronic regions, as well as the -1 kb 5' upstream promoter region, were thoroughly sequenced and analyzed. Despite extensive sequencing, no mutation was found in this 3.7 kb area. The 11beta-hydroxylase defect, closely mimicking the clinical and biochemical phenotype of classic 21-OHD, was excluded by directly sequencing 2.6 kb covering the entire coding of the CYP11B1 gene. Herein we describe a phenotypically and hormonally affected patient with classic simple virilizing 21-OHD CAH who lacks a mutation in the entire CYP21 gene and coding region of the CYP11B1 gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920112     DOI: 10.1210/jcem.84.1.5554

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Identification and functional characterization of a novel mutation P459H and a rare mutation R483W in the CYP21A2 gene in two Chinese patients with simple virilizing form of congenital adrenal hyperplasia.

Authors:  L Jiang; L L Song; H Wang; J L Wang; P P Wang; H B Zhou; X L Zhang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

3.  Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.

Authors:  Maria I New; Moolamannil Abraham; Brian Gonzalez; Miroslav Dumic; Maryam Razzaghy-Azar; David Chitayat; Li Sun; Mone Zaidi; Robert C Wilson; Tony Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

4.  The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency.

Authors:  Larissa G Gomes; Ningwu Huang; Vishal Agrawal; Berenice B Mendonça; Tania A S S Bachega; Walter L Miller
Journal:  J Clin Endocrinol Metab       Date:  2008-04-08       Impact factor: 5.958

5.  Structure-based analysis of five novel disease-causing mutations in 21-hydroxylase-deficient patients.

Authors:  Carolina Minutolo; Alejandro D Nadra; Cecilia Fernández; Melisa Taboas; Noemí Buzzalino; Bárbara Casali; Susana Belli; Eduardo H Charreau; Liliana Alba; Liliana Dain
Journal:  PLoS One       Date:  2011-01-11       Impact factor: 3.240

6.  Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines.

Authors:  Christopher N Greene; Suzanne K Cordovado; Daniel P Turner; Lisa M Keong; Dorothy Shulman; Patricia W Mueller
Journal:  Mol Genet Metab Rep       Date:  2014-08-08

7.  Functional studies of p.R132C, p.R149C, p.M283V, p.E431K, and a novel c.652-2A>G mutations of the CYP21A2 gene.

Authors:  Melisa Taboas; Luciana Gómez Acuña; María Florencia Scaia; Carlos D Bruque; Noemí Buzzalino; Mirta Stivel; Nora R Ceballos; Liliana Dain
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Deficient pregnenolone synthesis associated with congenital adrenal hyperplasia and organelle dysfunction.

Authors:  Himangshu S Bose; Alan M Rice; Brendan Marshall; Fadi Gebrail; David Kupshik; Elizabeth W Perry
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-05-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.